With the FDA expecting to approve 10–20 Cell and Gene Therapies (CGTs) annually by 2025, it is evident that the field will continue to hold immense commercial and medical opportunities. To harness ...
FDA's draft guidance shows gene therapy developers how to use prior knowledge and platform data to accelerate regulatory ...
A cutting-edge procedure for treating sickle cell disease is changing lives in the St. Louis area, where an estimated 1,200 ...
This story is part of a series on the current progression in Regenerative Medicine. In 1999, I defined regenerative medicine as the collection of interventions that restore tissues and organs damaged ...
A strategic CDMO partnership brings together scientific expertise, manufacturing capabilities, and shared goals to advance ...
LOS ANGELES, Sept 28 (Reuters) - Student Zoe Davis, 20, was just weeks into her junior year when she landed back in the hospital with severe sickle cell pain earlier this month. She is doing what she ...
Forbes contributors publish independent expert analyses and insights. William A. Haseltine, Ph.D., covers genomics and regenerative medicine This voice experience is generated by AI. Learn more. This ...
BUFFALO, N.Y. — A viral gene therapy developed by University at Buffalo researchers has reversed some brain abnormalities in infant mice with FOXG1 syndrome, a significant step toward one day treating ...
“I was a really, really sick kid,” said Kyle A. Smith, who underwent his first surgery at 3 months old after sickle-cell disease caused blood to become trapped in his spleen. He estimates he has been ...
All Evaluable Patients Achieved Improvements in Multiple Hallmarks of MYBPC3-Associated HCM Benefits Among Cohort 1 Patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results